NEW YORK--(BUSINESS WIRE)--Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, is investigating into whether MiMedx Group Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG) or its officers and directors violated federal securities laws. If you purchased MiMedx securities, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.
MiMedx is a medical device company.
On February 20, 2018, pre-market, MiMedx announced that it was postponing the release of its fourth quarter and fiscal year 2017 financial results. The Company also announced that its Audit Committee is conducting “an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company.”
On this news, the Company’s stock is down more than 37% as of the time of this writing.
What You Can Do
If you purchased MiMedx securities, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at (844) 818-6982, or at firstname.lastname@example.org, or visit https://scott-scott.com/investigation/mimedx-group-inc/.
About Scott+Scott, Attorneys at Law, LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.